The Synergistic Combination of Cisplatin and Piperine Induces Apoptosis in MCF-7 Cell Line
- PMID: 34183962
- PMCID: PMC8223570
- DOI: 10.18502/ijph.v50i5.6121
The Synergistic Combination of Cisplatin and Piperine Induces Apoptosis in MCF-7 Cell Line
Abstract
Background: Piperine is a natural compound obtained from the Piper nigrum that exhibits anti-proliferative and anti-cancer activity in cancer cell lines. We analyzed the cytotoxic effect of piperine combined with cisplatin compound in the human MCF-7 breast cancer cell line and the underlying mechanism.
Methods: The present in vitro study was performed on MCF-7 cell line in Jahrom University of Medical Sciences between, Jahrom, Iran from 2016 to 2017. Cultured MCF-7 cells were seeded into four groups: a control group (untreated group), a group treated with cisplatin, a group treated with piperine and a group treated with cisplatin and piperine. Cell viability was analyzed using the MTT assay method. Flow c-ytometric analysis was investigated for apoptosis. The mRNA and protein expression of the apoptotic regulators p53, Bcl-2, Bax, caspase 3 and caspase 9 were detected by quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting analysis.
Results: Piperine (20 and 30 μM) in combination with cisplatin (5, 10 and 15 μM) for 24 h synergistically inhibited cell viability of MCF-7 breast cancer cells more than piperine and cisplatin used alone. Synergistic anti-breast cancer activities cisplatin (5 μM) and piperine (20 μM) were via inducing apoptosis. Piperine (20 μM) and cisplatin (5 μM) for 24 h induce apoptosis strongly through reduction of Bcl-2 and increase of caspase 3, p53, caspase 9, and Bax.
Conclusion: Piperine in combination with cisplatin could trigger p53-mediated apoptosis more effective than cisplatin alone in MCF-7 breast cancer cells, reducing the toxic dose of cisplatin used in cancer chemotherapy.
Keywords: Apoptosis; Breast cancer; Caspase; Cisplatin; Piperine.
Copyright © 2021 Fattah et al. Published by Tehran University of Medical Sciences.
Conflict of interest statement
Conflict of interest The authors declare that there is no conflict of interest.
Figures




References
-
- DeSantis CE, Ma J, Goding Sauer A, et al. (2017). Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin, 67(6):439–448. - PubMed
-
- Abazari O, Divsalar A, Ghobadi R. (2019). Inhibitory effects of oxali-Platin as a chemotherapeutic drug on the function and structure of bovine liver catalase. J Biomol Struct Dyn, 38(2):609–615. - PubMed
-
- Petrović M, Todorović D. (2016). Biochemical and molecular mechanisms of action of cisplatin in cancer cells. Facta Univ Ser Med Biol, 12–18.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous